Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela D Weber

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Cancer|May 2, 2026
Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid CancerCelina Ablinger, Petra Huber-Cantonati, Daniela D Weber, et al.
Metabolites|August 25, 2023
Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma XenograftsLuca Catalano, Sepideh Aminzadeh-Gohari, Daniela D Weber, et al.
Cancer & Metabolism|July 19, 2022
Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticityDaniela D Weber, Sepideh Aminzadeh-Gohari, Maheshwor Thapa, et al.
Communications Medicine|April 2, 2025
Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measuresJames E Barrett, Chiara Maria Herzog, Sepideh Aminzadeh-Gohari, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Cancer|May 2, 2026
Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid CancerCelina Ablinger, Petra Huber-Cantonati, Daniela D Weber, et al.
Metabolites|August 25, 2023
Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma XenograftsLuca Catalano, Sepideh Aminzadeh-Gohari, Daniela D Weber, et al.
Cancer & Metabolism|July 19, 2022
Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticityDaniela D Weber, Sepideh Aminzadeh-Gohari, Maheshwor Thapa, et al.
Communications Medicine|April 2, 2025
Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measuresJames E Barrett, Chiara Maria Herzog, Sepideh Aminzadeh-Gohari, et al.
Pageof 2